Another study also showed that NOX-4 mRNA levels were reduced in plaques from patients with cardiovascular events or established diabetes mellitus which was found that, together with experimental studies, pointed to a possible role of NOX-4 as a negative modulator of inflammation and remodeling to convey atheroprotection [36]. The gene discussed is NOX4; the disease is diabetes mellitus.